Edwards FloTrac™ sensor and Vigileo™ monitor:: easy, accurate, reliable cardiac output assessment using the arterial pulse wave
Edwards FloTrac™ sensor and Vigileo™ monitor:: easy, accurate, reliable cardiac output assessment using the arterial pulse wave
复制标题
DOI：
10.1586/17434440.2.5.523
复制
发表时间：
2005-09-01
影响因子：
3.1
通讯作者：
Manecke, Gerard R.
中科院分区：
文献类型：
--
作者：
Manecke, Gerard R.
Edwards Lifesciences最近推出了FloTraC（TM）传感器和Vigileo（TM）监测系统，用于连续监测心输出量。它不需要热稀释或染料稀释，而是根据动脉波形特征以及患者人口统计数据进行计算。它在动脉波形心输出量系统中是独一无二的，因为它不需要用另一种方法进行校准。迄今为止的研究表明，它在广泛的心输出量和临床条件下是稳健和准确的。它将在许多患者的护理中具有价值，例如那些患有危重病，心血管功能障碍，创伤或接受大手术的患者。
Edwards Lifesciences has recently introduced the FloTraC(TM) sensor and Vigileo(TM) monitor system for monitoring cardiac output continuously. It does not require thermodilution or dye dilution, but rather bases its calculations on arterial waveform characteristics in conjunction with patient demographic data. It is unique among arterial waveform cardiac output systems in that it does not require calibration with another method. Studies thus far indicate that it is robust and accurate over a wide range of cardiac output and clinical conditions. It will be valuable in the care of many patients, such as those with critical illness, cardiovascular dysfunction, trauma or undergoing major surgery.